CCD 1042: COCN began a Phase II trial in children

CoCensys Inc. (COCN), Irvine, Calif. Product: CCD 1042, epalon (neuroactive steroid) anticonvulsant Indication: Epilepsy unresponsive to other therapies Status: COCN began a Phase II trial in 20 child...